Medical treatment beyond ACE inhibition: false promise or lack of vision?
作者信息
Walsh J T, Cowley A J
机构信息
University Hospital, Nottingham.
出版信息
Br Heart J. 1994 Sep;72(3 Suppl):S100-5. doi: 10.1136/hrt.72.3_suppl.s100.
Abstract
摘要
相似文献
1
Medical treatment beyond ACE inhibition: false promise or lack of vision?除血管紧张素转换酶抑制剂之外的医学治疗：虚假承诺还是缺乏远见？
Br Heart J. 1994 Sep;72(3 Suppl):S100-5. doi: 10.1136/hrt.72.3_suppl.s100.
2
[Drug therapy of cardiac failure].
Nihon Naika Gakkai Zasshi. 1998 Mar 10;87(3):553-9.
3
The treatment of congestive heart failure with diuretics and nondiuretic agents.
Clin Ther. 1988;10(4):328-49.
4
[Practical aspects of diagnosis, treatment and prognosis in chronic heart failure].[慢性心力衰竭诊断、治疗及预后的实践要点]
Dtsch Med Wochenschr. 1999 Mar 12;124(10):291-5. doi: 10.1055/s-2007-1024298.
5
A 75-year-old man with congestive heart failure.
JAMA. 1999;281(24):2321-8. doi: 10.1001/jama.281.24.2321.
6
[Current problems of pharmacotherapy--heart failure].[药物治疗的当前问题——心力衰竭]
Ther Umsch. 1990 Aug;47(8):686-92.
7
Current medical therapy for advanced heart failure.
Am Heart J. 1998 Jun;135(6 Pt 2 Su):S231-48. doi: 10.1016/s0002-8703(98)70253-4.
8
Drugs for chronic heart failure.
Med Lett Drugs Ther. 1996 Oct 11;38(985):92-4.
9
Clinical case studies in heart failure management.心力衰竭管理中的临床病例研究
Br J Clin Pharmacol. 1999 Mar;47(3):239-47. doi: 10.1046/j.1365-2125.1999.00882.x.
10
Drugs for chronic heart failure.
Med Lett Drugs Ther. 1999 Jan 29;41(1045):12-4.
本文引用的文献
1
The search for the ideal positive inotropic agent.对理想正性肌力药物的探索。
N Engl J Med. 1993 Jul 15;329(3):201-2. doi: 10.1056/NEJM199307153290310.
2
Effects of vesnarinone on morbidity and mortality in patients with heart failure. Vesnarinone Study Group.维司力农对心力衰竭患者发病率和死亡率的影响。维司力农研究小组。
N Engl J Med. 1993 Jul 15;329(3):149-55. doi: 10.1056/NEJM199307153290301.
3
Central hemodynamic effects of diuretic therapy in chronic heart failure.利尿剂治疗对慢性心力衰竭的中心血流动力学影响
Cardiovasc Drugs Ther. 1993 Jan;7 Suppl 1:45-53. doi: 10.1007/BF00877957.
4
Isolated ultrafiltration in moderate congestive heart failure.
J Am Coll Cardiol. 1993 Feb;21(2):424-31. doi: 10.1016/0735-1097(93)90685-t.
5
Fat-suppressed breath-hold magnetic resonance coronary angiography.
Circulation. 1993 Jan;87(1):94-104. doi: 10.1161/01.cir.87.1.94.
6
Adenosine-sensitive ventricular tachycardia. Clinical characteristics and response to catheter ablation.腺苷敏感性室性心动过速。临床特征及对导管消融的反应
Circulation. 1993 Jan;87(1):126-34. doi: 10.1161/01.cir.87.1.126.
7
Hemodynamic and neurohormonal effects of the angiotensin II antagonist losartan in patients with congestive heart failure.血管紧张素II拮抗剂氯沙坦对充血性心力衰竭患者的血流动力学及神经激素影响
Circulation. 1993 Oct;88(4 Pt 1):1602-9. doi: 10.1161/01.cir.88.4.1602.
8
Lack of effect of nitrates on exercise tolerance in patients with mild to moderate heart failure caused by coronary disease already treated with captopril.硝酸盐对已接受卡托普利治疗的冠心病所致轻至中度心力衰竭患者运动耐量无影响。
Br Heart J. 1993 Jul;70(1):17-21. doi: 10.1136/hrt.70.1.17.
9
Beta blockers and the failing heart: is it time for a U-turn?β受体阻滞剂与衰竭心脏：是时候转向了吗？
Br Heart J. 1993 Jul;70(1):8-12. doi: 10.1136/hrt.70.1.8.
10
Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy. Metoprolol in Dilated Cardiomyopathy (MDC) Trial Study Group.美托洛尔对特发性扩张型心肌病的有益作用。美托洛尔治疗扩张型心肌病（MDC）试验研究组。
Lancet. 1993 Dec 11;342(8885):1441-6. doi: 10.1016/0140-6736(93)92930-r.
Zotero 插件